Acquired Resistance of EGFR-Mutant Lung Cancer to a T790M-Specific EGFR Inhibitor: Emergence of a Third Mutation (C797S) in the EGFR Tyrosine Kinase Domain. Article uri icon

Overview

publication date

  • October 1, 2015

Research

keywords

  • Adenocarcinoma
  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Drug Resistance, Neoplasm
  • ErbB Receptors
  • Lung Neoplasms
  • Mutation
  • Protein Kinase Inhibitors

Identity

PubMed Central ID

  • PMC4665629

Scopus Document Identifier

  • 84987849616

Digital Object Identifier (DOI)

  • 10.1001/jamaoncol.2015.1066

PubMed ID

  • 26181354

Additional Document Info

volume

  • 1

issue

  • 7